Episodes 1-15 of 76
Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
MinuteCE®Episode 1 Part B: Diagnosis, Monitoring, and Risk Assessment
Episode 2 Part A: The “High Risk” Patient: What Providers Need to Know
MinuteCE®Episode 2 Part A: The “High Risk” Patient: What Providers Need to Know
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
MinuteCE®Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Episode 1 Part A: Signs and Symptoms of CKD and T2D
MinuteCE®Episode 1 Part A: Signs and Symptoms of CKD and T2D
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
MinuteCE®Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Establishing a Best Practice Between Primary Care and Specialists
MinuteCE®Establishing a Best Practice Between Primary Care and Specialists
Managing Symptom Clusters in Patients on Hemodialysis With CKD-aP
CME/CEManaging Symptom Clusters in Patients on Hemodialysis With CKD-aP
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
CME/CEAdvancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Call to Action: Utilizing Avacopan to Improve AAV Care
CME/CECall to Action: Utilizing Avacopan to Improve AAV Care
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MinuteCE®MACE and SGLT2 Inhibitors: Do They Have an Impact?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
MinuteCE®Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Staging Coronary Risk: A New TRANSFORMative Approach
MinuteCE®Staging Coronary Risk: A New TRANSFORMative Approach
TRANSFORM Trial: Overview and Potential Implications
MinuteCE®TRANSFORM Trial: Overview and Potential Implications
